-
Production shrinks, imports are blocked, and turmeric prices rise!
Time of Update: 2021-08-05
In recent years, due to the impact of foreign low-priced goods, the domestic authentic variety Chuan turmeric has suffered from low prices and shrinking planting areas, which has attracted market attention .
-
BMS withdraws Opdivo monotherapy for sorafenib treatment failure indication for hepatocellular carcinoma
Time of Update: 2021-08-05
However, in the confirmatory clinical trial CheckMate-459, Opdivo and Sorafenib head-to-head first-line treatment of patients with hepatocellular carcinoma in the pre-specified analysis, the primary endpoint of overall survival did not reach statistical significance .
-
The Qinghai Sea line medical insurance information platform helps solve the problem of "errands and time-consuming"
Time of Update: 2021-08-05
The relevant person in charge of the Qinghai Provincial Medical Security Bureau said that after the platform is launched, it will create more efficient, convenient, high-quality and safe medical insurance public service conditions for more than 5.
-
Sichuan pharmaceutical companies are showing off!
Time of Update: 2021-08-05
Recently, the good news of Better Pharmaceutical’s product line has continued: Cefmetazole Sodium for Injection was the first to have been evaluated, the first class new drug BT-101094 capsule was approved for clinical use, and it has reached a cooperation with Guangzhou Kangchen in the field of contrast agents .
-
Zhengzhou's epidemic presents three major characteristics
Time of Update: 2021-08-04
Zhengzhou This epidemic has a fast spreading speed, high viral load, and a state of local spread Xinhua News Agency, Zhengzhou, July 31st (Reporters Liu Huaipi and Wang Shuo) On the 31st, at a press conference on the prevention and control of the new crown pneumonia epidemic in Zhengzhou, Wang Songqiang, director of the Zhengzhou Center for Disease Control and Prevention, introduced that the epidemic in Zhengzhou was spreading fast and carrying the virus.
-
There is not enough evidence to show that the whole population needs a third shot of the new crown vaccine
Time of Update: 2021-08-04
Shao Yiming, the chief expert and researcher of the Chinese Center for Disease Control and Prevention, said at the press conference that all countries are conducting research on booster immunization of the new crown vaccine, and there is not enough evidence to show that the entire population needs to be vaccinated with a third dose .
-
Health Commission: 75 newly diagnosed local cases and 53 new cases on the 31st
Time of Update: 2021-08-04
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 31 The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on July 31 The l
-
Swiss biologist: traceability of the new crown virus may become a political tool
Time of Update: 2021-08-04
Swiss biologist Wilson Edwards recently posted on his social media that some sources from the World Health Organization and some other scientists told him that in the past period of time, due to their Supported the conclusions of the China-WHO Joint Research Report on the Traceability of the New Coronavirus, and was pressured and intimidated by the United States .
-
2021 Fortune Global 500 released 34 pharmaceutical-related companies on the list
Time of Update: 2021-08-04
6 China 437 Shanghai Pharmaceutical Group 27812.
6 China 437 Shanghai Pharmaceutical Group 27812.
6 China 437 Shanghai Pharmaceutical Group 27812.
7 United States6 China 437 Shanghai Pharmaceutical Group 27812.
7 United States6 China 437 Shanghai Pharmaceutical Group 27812.
-
Delta mutant strains are still protected by existing vaccines
Time of Update: 2021-08-04
According to He Qinghua, the epidemic was triggered by the import of the delta mutant strain; it is currently summer vacation, where people gather in tourist resorts; the place where the population is dense, and it is an international airport with a relatively large flow of people, so there will still be continued transfers in the short term The risk of proliferation in other regions .
-
In the first half of the year, the number of new drugs approved by the National Bureau reached a new high, and my country's innovative drugs entered the stage of full-scale outbreak
Time of Update: 2021-08-04
In an open phase 3 clinical trial (NCT02253459), 405 patients with metastatic breast cancer received this product + capecitabine or capecitabine monotherapy at a ratio of 2:1, this product + card The median progression-free survival (PFS) of the patients in the petitabine treatment group was 8.
-
Health Commission: Newly confirmed 90 local cases and 61 new cases on the 2nd
Time of Update: 2021-08-04
The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on August 2 The latest situation of the novel coronavirus pneumonia epidemic as of 24:00 on August 2 The
-
Gao Fu: China realizes self-reliance and self-reliance in vaccine technology
Time of Update: 2021-08-04
Gao Fu said that China has achieved a high level of self-reliance in vaccine technology .
In recent years, China has made great progress in vaccine research and development, production, supply, and supervision.
-
The spreading chain of the epidemic in Nanjing continues to extend: how to prevent and control the epidemic in summer?
Time of Update: 2021-08-04
The current epidemic situation in mainland China includes further spread due to import from Nanjing Lukou Airport, as well as internal infections in Zhengzhou hospitals due to poor protection.
-
Hengrui's entry of 1.5 billion original anesthetic drugs is hit again
Time of Update: 2021-08-04
Wonderful contentWonderful contentA few days ago, Hengrui Medicine issued an announcement stating that the company has obtained approval for its imitation of Propofol medium/long-chain fat emulsion injections for production of 4 categories, and it is deemed to have been reviewed .
-
Expert: Evidence should be emphasized, rather than political factors as the mainstream of traceability
Time of Update: 2021-08-04
Expert: Evidence should be emphasized instead of political factors as the mainstream of traceability work How to trace the source of the new coronavirus?
In this regard, Wang Guangfa pointed out that the traceability work of the new coronavirus must first clarify the time sequence of the emergence of the virus.
-
Trace the source of the Nanjing epidemic to lock it!
Time of Update: 2021-08-04
According to statistics from the US Centers for Disease Control and Prevention, in May of this year, only 1% of the new cases in the United States were infected with the Delta strain.
-
Health Commission: 64 new confirmed cases, of which 21 were from the mainland
Time of Update: 2021-08-04
Health Commission: 64 new confirmed cases, of which 21 were from the mainland Health Commission: 64 new confirmed cases, including 21 in the local area. Health Commission: 64 new c
-
Gao Fu: If the world does not share the vaccine, the virus will share the world
Time of Update: 2021-08-04
academician China Ke Xueyuan Academy of Sciences , National Center for Drug Research and Development expert committee will be members of the Chen Kaixian we believe that with the Chinese medicine industry, a group of biomedical science and technology innovation enterprise can flourish, and gradually have the ability to carry out pre-standardized clinical and clinical studies of new drugs, which will affect And change the pattern of new drug research in China .
-
Pharmaceutical giants semi-annual report PK!
Time of Update: 2021-08-04
Products approved after 2012 contributed more than 11 billion Swiss francs in sales in the first half of the year, an increase of 30%, and accounted for more than 50% of the total sales of the pharmaceutical sector .